{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:15:05Z","timestamp":1785330905088,"version":"3.55.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,4]]},"DOI":"10.1093\/oncolo\/oyaf117","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T05:59:01Z","timestamp":1749880741000},"source":"Crossref","is-referenced-by-count":1,"title":["Adverse health outcomes in testis cancer survivors\u2014the price for our success?"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5942-8679","authenticated-orcid":false,"given":"Danish","family":"Mazhar","sequence":"first","affiliation":[{"name":"Department of Oncology, Cambridge University Hospitals NHS Foundation Trust , Cambridge, Cambs CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Heritage","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cambridge University Hospitals NHS Foundation Trust , Cambridge, Cambs CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cambridge University Hospitals NHS Foundation Trust , Cambridge, Cambs CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"2025061401585648800_CIT0001","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.eururo.2019.07.002","article-title":"International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries","volume":"76","author":"Gurney","year":"2019","journal-title":"Eur Urol"},{"key":"2025061401585648800_CIT0002","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/bjc.1983.99","article-title":"The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)","volume":"47","author":"Peckham","year":"1983","journal-title":"Br J Cancer"},{"key":"2025061401585648800_CIT0003","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","article-title":"Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide","volume":"316","author":"Williams","year":"1987","journal-title":"N Engl J Med"},{"key":"2025061401585648800_CIT0004","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J Clin Oncol"},{"key":"2025061401585648800_CIT0005","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/jnci\/89.19.1429","article-title":"Risk of second malignant neoplasms among long-term survivors of testicular cancer","volume":"89","author":"Travis","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"2025061401585648800_CIT0006","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J Clin Oncol"},{"key":"2025061401585648800_CIT0007","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1200\/JCO.2017.77.4174","article-title":"Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era","volume":"36","author":"Groot","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025061401585648800_CIT0008","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jamaoncol.2016.3651","article-title":"Second malignant neoplasms and cause of death in patients with germ cell cancer: a Danish nationwide cohort study","volume":"2","author":"Kier","year":"2016","journal-title":"JAMA Oncol"},{"key":"2025061401585648800_CIT0009","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2025061401585648800_CIT0010","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/andr.12177","article-title":"Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis","volume":"4","author":"Bandak","year":"2016","journal-title":"Andrology"},{"key":"2025061401585648800_CIT0011","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/pon.4596","article-title":"A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors","volume":"27","author":"Smith","year":"2018","journal-title":"Psychooncology"},{"key":"2025061401585648800_CIT0012","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1200\/jco.2005.05.061","article-title":"Study of anxiety disorder and depression in long-term survivors of testicular cancer","volume":"23","author":"Dahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"2025061401585648800_CIT0013","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1365-2354.2012.01366.x","article-title":"Suicide in men with testis cancer","volume":"21","author":"Alanee","year":"2012","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2025061401585648800_CIT0014","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1200\/JCO.21.00637","article-title":"Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort","volume":"39","author":"Hellesnes","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025061401585648800_CIT0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/djk111","article-title":"Platinum exposure and cause-specific mortality among patients with testicular cancer. Cancer 2020; 126:628-639. 16. Fossa SD, Gilbert E, Dores GM, et al: Noncancer causes of death in survivors of testicular cancer","volume":"99","author":"Groot","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2025061401585648800_CIT0016","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/jnci\/djk111","article-title":"Noncancer causes of death in survivors of testicular cancer","volume":"99","author":"Fossa","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2025061401585648800_CIT0017","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1200\/JCO.2016.70.3108","article-title":"Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy","volume":"35","author":"Fung","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025061401585648800_CIT0018","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1200\/JCO.2017.77.0735","article-title":"Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multiinstitutional study","volume":"36","author":"Kerns","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025061401585648800_CIT0019","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1200\/JCO.18.01480","article-title":"Serum levels of MicroRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: Results of a prospective multicentric study","volume":"37","author":"Dieckmann","year":"2019","journal-title":"J Clin Oncol"},{"key":"2025061401585648800_CIT0020","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/annonc\/mds579","article-title":"Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third consensus conference on diagnosis and treatment of germ cell cancer","volume":"24","author":"Beyer","year":"2013","journal-title":"Ann Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/6\/oyaf117\/63488945\/oyaf117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/6\/oyaf117\/63488945\/oyaf117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T05:59:01Z","timestamp":1749880741000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyaf117\/8162461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyaf117","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,6]]},"article-number":"oyaf117"}}